The Circle HealthPod gives PCR quality results in 20 minutes.
The Rapid Detection System will eventually work for a variety of infectious diseases, but is starting with the Coronavirus.
Developed at the University of Oxford, each pocket-sized test is designed to be used more than 1000 times, with results sent to your smartphone.
Prospective studies comparing Circle HealthPod to highly sensitive FDA-approved PCR lab tests showed 96% sensitivity and 99.9% specificity.
Hong Kong-based firm New World Development has now secured 10,000 Circle HealthPods and 60,000 single-use capsules, with a retail value of HK $16.49million.
Prenetics Limited, a global leader in diagnostics and genetic testing, is also involved with the Circle HealthPods, which is a nasal swab test.
Danny Yeung, Co-Founder and Group CEO of Prenetics, said: "The Circle HealthPod is the first of its kind and we believe it will change how consumers consume healthcare. We imagine a future where every household and every office will have a Circle HealthPod, capable of testing for all infectious diseases without ever having to step foot outside.
"Our mission at Prenetics has always been to decentralize healthcare and today's announcement with NWD marks a significant milestone."
Starting from today, Prenetics has set up a store in Hong Kong shopping center K11 MUSEA, to showcase Circle HealthPod products.
Professor Zhanfeng Cui, Donald Pollock Professor of Chemical Engineering, University of Oxford, said, "At the onset of the pandemic in early 2020, my team at the University of Oxford started to work on rapid diagnostics so that we could contribute to society. Our goal at the time was to develop the technology for any individual to be able to perform a rapid self-test with PCR-quality results, anywhere, anytime, without a laboratory.
"I couldn't be more proud of today's announcement by Prenetics and New World Development on the launch of the Circle HealthPod. We look forward to seeing HealthPod brought to the global community. Development has already started on capsules to detect influenza and other infectious diseases."